Is JNJ a Buy? Johnson Stock Analysis & Fair Value (2025)
Our model currently rates JNJ as a Buy.
Get the latest investment score, DCF valuation, and buy/sell/hold insights for Johnson & Johnson (JNJ).
Stock Analysis & Score Explanation
- ✓Fundament Score Analysis
- ✓Fair Value Analysis
Fair Value Analysis
Weighted Fair Value
$333.86
Based on Multiple Valuation Methods (Weighted Average)
Current Price
$207.56
Individual Valuation Methods:
DCF Model Assumptions:
Stock Analysis & Score Explanation
This stock receives a score of 68.51/100 with a Buy recommendation. Financial health scored 43.64/55, competitive position 14.5/25, macro risk assessment 8.34/10, and risk-adjusted returns 2.02/10. The analysis considers current market conditions and fundamental metrics. This score reflects the financial health, growth potential, and overall valuation of the stock, helping investors determine whether it may be overvalued or undervalued. Learn more about the AInvestor Score and how it is calculated. See how we convert scores and fair-value signals into actionable labels in the AInvestor Recommendation glossary entry.
Undervalued by 60.85%. Our detailed stock valuation analysis indicates that undervalued at current market prices by 60.85%. The weighted fair value of $333.86 is calculated using multiple proven valuation methods, including Discounted Cash Flow (DCF), Peter Lynch Fair Value, Trading Multiples P/E, and Earnings Power Value (EPV). This comprehensive stock analysis is designed to guide informed investment decisions.